J Korean Neurosurg Soc.  1990 Jan;19(1):5-13.

The Effects of Nimodipine on Neurological and Pathological Findings Following Experimental Focal Cerebral Ischemia

Affiliations
  • 1Department of Neurosurgery, Hallym University College of Medicine, Korea.
  • 2Department of Anatomy, Yonsei University College of Medicine, Korea.

Abstract

Two major factors, delayed hypoperfusion and membrane failure influence the sequelae of cerebral ischemic injury. Calcium ions play a major role in both pathophysiological mechanisms. Calcium channel blockers are a logical choice for investigation as possible therapeutic agents for the treatment of cerebral ischemia. Nimodipine, a dihydropyridine derivative, is one of the most potent calcium channel blocking agent with a selective action on the intracranial vessels. The present study was designed to test the effects of nimodipine on focal cerebral ischemia in rats. At 1,2 or 6 hours after occlusion of the middle cerebral artery(MCA), rats were treated with either nimodipine or saline. Neurological and pathological evaluation was performed at 24 hours after occlusion. Neurological outcome was better in nimodipine-treated rats and the size of the infarcted area was statistically smaller in rats treated with nimodipine 1,2 or 6 hours after occlusion(P<0.001, P<0.001, P<0.001, respectively) when compared with control rats(MCA occlusion only) or saline-treated rats. The results show that nimodipine improves neurological outcome and decreases the size of infarction after ischemic insult. The mechanism of action of nimodipine is not fully understood but nimodipine could influence cerebral postischemic changes by improving blood flow and/or by a direct action on neurons.

Keyword

Nimodipine; Focal cerebral ischemia; Hypoperfusion; Membrane failure

MeSH Terms

Animals
Brain Ischemia*
Calcium
Calcium Channel Blockers
Calcium Channels
Infarction
Ions
Logic
Membranes
Neurons
Nimodipine*
Rats
Calcium
Calcium Channel Blockers
Calcium Channels
Ions
Nimodipine
Full Text Links
  • JKNS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr